October 24, 2006 at 5:39 am · Filed under Medical News
AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) has approved SEROQUEL® (quetiapine fumarate) for the treatment of patients with depressive episodes associated with bipolar disorder. SEROQUEL already is approved for the treatment of acute manic episodes associated with bipolar I disorder and for the treatment of schizophrenia. SEROQUEL is now the first and only single medication approved by the FDA to treat both depressive and manic episodes associated with bipolar disorder.
Read the rest of this entry »
October 23, 2006 at 5:43 am · Filed under Medical News, Primary Care / General Practice News
* “Leapfrog Hospital Quality and Safety Survey,” The Leapfrog Group: The survey evaluated 1,200 hospitals nationwide to determine the state of health care quality and safety in U.S. hospitals. Using the survey results, Leapfrog named 59 participating hospitals to the first Leapfrog Top Hospitals list. The survey found that nine in 10 hospitals have policies in place to avoid operations on the wrong part of the body and that eight in 10 hospitals require prescriptions to be reviewed by a pharmacist before being given to patients. The survey also found that nine in 10 hospitals did not meet standards for two high-risk surgeries and that five in 10 did not have a policy to ensure adequate nurse staffing (The Leapfrog Group, “Leapfrog Hospital Quality and Safety Survey,” 10/16).
Read the rest of this entry »
